Rheumatoid Arthritis Clinical Trials in Philadelphia

Showing 41-60 of 2,974 trials

MMA Embolization for Refractory Chronic Migraine

NCT06735833

This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.

Migraine

Cerenovus, Part of DePuy Synthes Products, Inc.70 participantsStarted Apr 2025

Phoenix, Arizona, United States • Walnut Creek, California, United States • Hartford, Connecticut, United States +6 more locations

RECRUITINGPhase 3< 1 mile

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

NCT07052903

The purpose of this study is to: * Evaluate the efficacy of nucresiran compared to placebo on reducing all-cause mortality and cardiovascular (CV) events * Evaluate the efficacy of nucresiran compared to placebo on additional assessments of CV events and/or death * Evaluate the efficacy of nucresiran compared to placebo on patient-reported health status and health-related quality of life

Transthyretin Amyloidosis With Cardiomyopathy

Alnylam Pharmaceuticals1,250 participantsStarted Jul 2025

La Jolla, California, United States • Stanford, California, United States • Norwich, Connecticut, United States +204 more locations

MMA Embolization for Refractory Chronic Migraine

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Rheumatoid Arthritis Trials in Other Cities

Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis

Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Fecal Microbiome Transplant

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT

A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

Clinical Decision Support Tool in PARDS Pilot Study

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

A Safety Surveillance Study in Subjects With Macular Degenerative Disease Treated With Human Embryonic Stem Cell-derived Retinal Pigment Epithelial Cell Therapy

Other Conditions in Philadelphia